+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial)



Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial)



European Journal of Cancer 45(18): 3282-3290



To assess the feasibility, participation and neoplasia yield of adding a flexible sigmoidoscopy (FS) once in a lifetime to a colorectal cancer screening programme with guaiac-based faecal occult blood test (gFOBT). A total of 4771 average risk residents aged 50-74 of a canton of the Haut-Rhin, a French administrative area, were invited every other year to participate in an organised screening programme with gFOBT. Of them, those aged 55-64 (1824 people) were, in addition, invited once by mail to visit their general practitioner (GP) for a screening with FS performed by a gastroenterologist. In all, 2717 people (56.9%) (95% confidence interval (CI) 55.5-58.4) were screened with one or other of the two tests or with both tests. Compliance was 56.7% (55.3-58.1) with gFOBT and 20.9% (19.1-22.8) with FS. Both tests were performed by 20.2% (18.4-22.1) of people. Compliance with FS was 1.9% in people who had not complied with gFOBT and 31.9% in people who complied. The latter was 50% in patients of 26 motivated GPs. The detection rate for advanced neoplasia was 17.7 per 1000 people screened (12.7-22.6) with the combined procedure, more than three times higher than that with gFOBT alone. A population-based screening programme with the addition of FS to gFOBT is feasible and safe through an organisation involving GPs. The performances of the two screening tools are complementary: high compliance - low yield for gFOBT and vice versa for FS. The addition of a single FS screening in people aged 55-64 to an organised programme with biennial gFOBT in people aged 50-74 is a colorectal cancer screening option that deserves further exploration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052171450

Download citation: RISBibTeXText

PMID: 19665368

DOI: 10.1016/j.ejca.2009.06.015


Related references

T1109 Colorectal Cancer Screening with the Addition of Flexible Sigmoidoscopy to Guaiac-Based Fecal Occult Blood Testing: A Population-Based Controlled Trial. Gastroenterology 134(4): A-485, 2008

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59(1): 62-68, 2010

Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. British Journal of Surgery 84(9): 1274-1276, 1997

Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. European Journal of Cancer 46(11): 2059-2066, 2010

Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. Journal of Medical Screening 4(3): 142-146, 1997

Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. Journal of Medical Screening 22(2): 76-82, 2015

Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy?. Gut 61(7): 959-960, 2012

Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening. British Journal of Cancer 67(5): 1142-1144, 1993

Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317(7152): 182-185, 1998

Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British Journal of Cancer 74(1): 141-144, 1996

Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53(9): 1329-1333, 2004

A comparison of screening for colorectal cancer by flexible sigmoidoscopy and faecal occult blood testing with FOBT alone. Gastroenterology 110(4 Suppl. ): A491, 1996

Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. International Journal of Colorectal Disease 12(5): 291-295, 1997

T1094 Diagnostic Yield of Screening for Colorectal Cancer in the Netherlands; Randomized Controlled Trial Comparing Two Different Forms of Faecal Occult Blood Testing and Sigmoidoscopy. Gastroenterology 134(4): A-482, 2008

Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews 2013(9): Cd009259, 2013